Yerevanian B I, Koek R J, Feusner J D, Hwang S, Mintz J
Sepulveda Ambulatory Care Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Acta Psychiatr Scand. 2004 Dec;110(6):452-8. doi: 10.1111/j.1600-0447.2004.00437.x.
To compare the rates of suicidal behaviour during vs. after discontinuation of treatment with antidepressants, and to determine the comparative rates of suicidal behaviour for patients maintained on tricyclic (TCA) vs. selective serotonin reuptake inhibitor (SSRI) antidepressants.
Charts were reviewed for 521 patients with major depressive disorder and/or dysthymic disorder. Periods of active treatment or discontinuation with SSRIs or TCAs were determined. Rates of completed suicide, suicide attempts, and hospitalization for suicidality were analyzed.
There was greater than a five-fold increase in risk for suicidal behaviour after discontinuation of antidepressant treatment (P < 0.0001). The rates of suicidal behavior during treatment with SSRIs or TCAs were similar.
Suicidal behaviour in unipolar depressed patients treated with antidepressants increases substantially after medication discontinuation. This effect occurred in both patients who were maintained on SSRIs and TCAs. The findings support a possible protective effect on suicidal behaviour for both SSRIs and TCAs.
比较使用抗抑郁药治疗期间与停药后自杀行为的发生率,并确定服用三环类抗抑郁药(TCA)与选择性5-羟色胺再摄取抑制剂(SSRI)的患者自杀行为的比较发生率。
对521例重度抑郁症和/或心境恶劣障碍患者的病历进行回顾。确定使用SSRI或TCA进行积极治疗或停药的时间段。分析自杀身亡、自杀未遂以及因自杀倾向住院的发生率。
抗抑郁药治疗停药后自杀行为的风险增加了五倍多(P < 0.0001)。使用SSRI或TCA治疗期间的自杀行为发生率相似。
接受抗抑郁药治疗的单相抑郁症患者停药后自杀行为大幅增加。这种效应在持续使用SSRI和TCA的患者中均有发生。这些发现支持SSRI和TCA对自杀行为可能具有保护作用。